nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—decidua—ovarian cancer	0.0107	0.0721	CbGeAlD
Gabapentin—BCAT1—endometrium—ovarian cancer	0.0102	0.0685	CbGeAlD
Gabapentin—BCAT1—gonad—ovarian cancer	0.00942	0.0635	CbGeAlD
Gabapentin—BCAT1—uterus—ovarian cancer	0.00936	0.0631	CbGeAlD
Gabapentin—CACNA1B—testis—ovarian cancer	0.00864	0.0582	CbGeAlD
Gabapentin—BCAT1—female reproductive system—ovarian cancer	0.00842	0.0567	CbGeAlD
Gabapentin—BCAT1—female gonad—ovarian cancer	0.00766	0.0516	CbGeAlD
Gabapentin—BCAT1—vagina—ovarian cancer	0.00761	0.0513	CbGeAlD
Gabapentin—CACNA2D2—vagina—ovarian cancer	0.00698	0.047	CbGeAlD
Gabapentin—BCAT1—testis—ovarian cancer	0.00679	0.0458	CbGeAlD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—NME2—ovarian cancer	0.00663	0.126	CbGpPWpGaD
Gabapentin—CACNA1B—lymph node—ovarian cancer	0.00626	0.0422	CbGeAlD
Gabapentin—CACNA2D2—testis—ovarian cancer	0.00623	0.042	CbGeAlD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—NSF—ovarian cancer	0.0057	0.109	CbGpPWpGaD
Gabapentin—ADORA1—female reproductive system—ovarian cancer	0.00536	0.0361	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—ovarian cancer	0.00524	0.0353	CbGeAlD
Gabapentin—CACNA2D1—female gonad—ovarian cancer	0.00505	0.034	CbGeAlD
Gabapentin—CACNA2D1—vagina—ovarian cancer	0.00502	0.0338	CbGeAlD
Gabapentin—BCAT1—lymph node—ovarian cancer	0.00492	0.0332	CbGeAlD
Gabapentin—ADORA1—vagina—ovarian cancer	0.00484	0.0326	CbGeAlD
Gabapentin—CACNA2D2—lymph node—ovarian cancer	0.00451	0.0304	CbGeAlD
Gabapentin—CACNA2D1—testis—ovarian cancer	0.00448	0.0302	CbGeAlD
Gabapentin—ADORA1—testis—ovarian cancer	0.00432	0.0291	CbGeAlD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA8—ovarian cancer	0.00406	0.0773	CbGpPWpGaD
Gabapentin—CACNA2D1—lymph node—ovarian cancer	0.00325	0.0219	CbGeAlD
Gabapentin—ADORA1—lymph node—ovarian cancer	0.00313	0.0211	CbGeAlD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA8—ovarian cancer	0.00226	0.0431	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—SLC2A1—ovarian cancer	0.00194	0.037	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00191	0.0364	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CCND2—ovarian cancer	0.00175	0.0333	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—NSF—ovarian cancer	0.00146	0.0279	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BIRC5—ovarian cancer	0.00135	0.0258	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TERT—ovarian cancer	0.00131	0.025	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00127	0.0241	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—SLC2A1—ovarian cancer	0.0012	0.0229	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.001	0.0191	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—FASN—ovarian cancer	0.000994	0.0189	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—NSF—ovarian cancer	0.00097	0.0185	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—SLC2A1—ovarian cancer	0.000944	0.018	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TOP1—ovarian cancer	0.000871	0.0166	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—ovarian cancer	0.000859	0.0164	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—PPP2R1A—ovarian cancer	0.000803	0.0153	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000761	0.0145	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—ovarian cancer	0.000736	0.014	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—HNF1B—ovarian cancer	0.00066	0.0126	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NME2—ovarian cancer	0.000609	0.0116	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—ovarian cancer	0.000608	0.0116	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—ovarian cancer	0.000499	0.00951	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—ovarian cancer	0.000479	0.00913	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYTB—ovarian cancer	0.000392	0.00748	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NME2—ovarian cancer	0.000369	0.00703	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPP1CC—ovarian cancer	0.000343	0.00653	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BRIP1—ovarian cancer	0.000343	0.00653	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TYMS—ovarian cancer	0.000307	0.00584	CbGpPWpGaD
Gabapentin—Pollakiuria—Doxorubicin—ovarian cancer	0.000266	0.000333	CcSEcCtD
Gabapentin—Pain—Paclitaxel—ovarian cancer	0.000265	0.000331	CcSEcCtD
Gabapentin—Constipation—Paclitaxel—ovarian cancer	0.000265	0.000331	CcSEcCtD
Gabapentin—Haematuria—Epirubicin—ovarian cancer	0.000264	0.000331	CcSEcCtD
Gabapentin—Confusional state—Docetaxel—ovarian cancer	0.000264	0.000331	CcSEcCtD
Gabapentin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000263	0.000329	CcSEcCtD
Gabapentin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000262	0.000328	CcSEcCtD
Gabapentin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000262	0.000328	CcSEcCtD
Gabapentin—Oedema—Docetaxel—ovarian cancer	0.000262	0.000328	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—ovarian cancer	0.000262	0.000328	CcSEcCtD
Gabapentin—Epistaxis—Epirubicin—ovarian cancer	0.000262	0.000327	CcSEcCtD
Gabapentin—Infection—Docetaxel—ovarian cancer	0.00026	0.000326	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—ovarian cancer	0.00026	0.000326	CcSEcCtD
Gabapentin—Sinusitis—Epirubicin—ovarian cancer	0.00026	0.000326	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00026	0.000325	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000259	0.00493	CbGpPWpGaD
Gabapentin—Pneumonia—Doxorubicin—ovarian cancer	0.000258	0.000323	CcSEcCtD
Gabapentin—Shock—Docetaxel—ovarian cancer	0.000258	0.000323	CcSEcCtD
Gabapentin—Nervous system disorder—Docetaxel—ovarian cancer	0.000257	0.000322	CcSEcCtD
Gabapentin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000257	0.000321	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—ovarian cancer	0.000257	0.000321	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—ovarian cancer	0.000257	0.000321	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—ovarian cancer	0.000257	0.000321	CcSEcCtD
Gabapentin—Tachycardia—Docetaxel—ovarian cancer	0.000256	0.00032	CcSEcCtD
Gabapentin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000255	0.000319	CcSEcCtD
Gabapentin—Skin disorder—Docetaxel—ovarian cancer	0.000255	0.000319	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000254	0.000318	CcSEcCtD
Gabapentin—Bradycardia—Epirubicin—ovarian cancer	0.000253	0.000317	CcSEcCtD
Gabapentin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000253	0.000317	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—ovarian cancer	0.000252	0.000316	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000252	0.000315	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—ovarian cancer	0.00025	0.000313	CcSEcCtD
Gabapentin—Stomatitis—Doxorubicin—ovarian cancer	0.00025	0.000313	CcSEcCtD
Gabapentin—Anorexia—Docetaxel—ovarian cancer	0.00025	0.000313	CcSEcCtD
Gabapentin—Rhinitis—Epirubicin—ovarian cancer	0.00025	0.000312	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000249	0.000312	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000249	0.000312	CcSEcCtD
Gabapentin—Hepatitis—Epirubicin—ovarian cancer	0.000249	0.000312	CcSEcCtD
Gabapentin—Haemorrhage—Epirubicin—ovarian cancer	0.000249	0.000312	CcSEcCtD
Gabapentin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000248	0.00031	CcSEcCtD
Gabapentin—Pharyngitis—Epirubicin—ovarian cancer	0.000247	0.000309	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—ovarian cancer	0.000246	0.000308	CcSEcCtD
Gabapentin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000246	0.000308	CcSEcCtD
Gabapentin—Urticaria—Paclitaxel—ovarian cancer	0.000246	0.000308	CcSEcCtD
Gabapentin—Oedema peripheral—Epirubicin—ovarian cancer	0.000245	0.000307	CcSEcCtD
Gabapentin—Hypotension—Docetaxel—ovarian cancer	0.000245	0.000307	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—ovarian cancer	0.000245	0.000306	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000245	0.000306	CcSEcCtD
Gabapentin—Body temperature increased—Paclitaxel—ovarian cancer	0.000245	0.000306	CcSEcCtD
Gabapentin—Abdominal pain—Paclitaxel—ovarian cancer	0.000245	0.000306	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—ovarian cancer	0.000244	0.000305	CcSEcCtD
Gabapentin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000243	0.000304	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—ovarian cancer	0.000242	0.000303	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—ovarian cancer	0.000241	0.000301	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—ovarian cancer	0.00024	0.0003	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HSD17B6—ovarian cancer	0.000239	0.00456	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000239	0.000299	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYTB—ovarian cancer	0.000238	0.00453	CbGpPWpGaD
Gabapentin—Insomnia—Docetaxel—ovarian cancer	0.000237	0.000297	CcSEcCtD
Gabapentin—Paraesthesia—Docetaxel—ovarian cancer	0.000235	0.000295	CcSEcCtD
Gabapentin—Erythema multiforme—Epirubicin—ovarian cancer	0.000235	0.000295	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—ovarian cancer	0.000234	0.000293	CcSEcCtD
Gabapentin—Dyspnoea—Docetaxel—ovarian cancer	0.000234	0.000293	CcSEcCtD
Gabapentin—Somnolence—Docetaxel—ovarian cancer	0.000233	0.000292	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—ovarian cancer	0.000233	0.000291	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—ovarian cancer	0.000232	0.00029	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—ovarian cancer	0.000231	0.000289	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—ovarian cancer	0.000231	0.000289	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—ovarian cancer	0.000231	0.000289	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—ovarian cancer	0.00023	0.000288	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—ovarian cancer	0.00023	0.000288	CcSEcCtD
Gabapentin—BCAT1—Metabolism—YAP1—ovarian cancer	0.00023	0.00438	CbGpPWpGaD
Gabapentin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000229	0.000287	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—ovarian cancer	0.000229	0.000286	CcSEcCtD
Gabapentin—Decreased appetite—Docetaxel—ovarian cancer	0.000228	0.000285	CcSEcCtD
Gabapentin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000228	0.000285	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000227	0.000285	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000227	0.000284	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000226	0.000283	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000226	0.000283	CcSEcCtD
Gabapentin—Fatigue—Docetaxel—ovarian cancer	0.000226	0.000283	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—ovarian cancer	0.000226	0.000283	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—ovarian cancer	0.000225	0.000281	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000224	0.000281	CcSEcCtD
Gabapentin—Pain—Docetaxel—ovarian cancer	0.000224	0.000281	CcSEcCtD
Gabapentin—Constipation—Docetaxel—ovarian cancer	0.000224	0.000281	CcSEcCtD
Gabapentin—Chills—Epirubicin—ovarian cancer	0.000223	0.00028	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—ovarian cancer	0.000222	0.000278	CcSEcCtD
Gabapentin—Asthenia—Paclitaxel—ovarian cancer	0.000222	0.000278	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—ovarian cancer	0.00022	0.000275	CcSEcCtD
Gabapentin—Pruritus—Paclitaxel—ovarian cancer	0.000219	0.000274	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—ovarian cancer	0.000218	0.000273	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000218	0.000273	CcSEcCtD
Gabapentin—Erythema—Epirubicin—ovarian cancer	0.000217	0.000271	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—ovarian cancer	0.000217	0.000271	CcSEcCtD
Gabapentin—Feeling abnormal—Docetaxel—ovarian cancer	0.000216	0.00027	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—ovarian cancer	0.000215	0.000269	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—ovarian cancer	0.000215	0.000269	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000214	0.000268	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—ovarian cancer	0.000214	0.000268	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—ovarian cancer	0.000214	0.000267	CcSEcCtD
Gabapentin—Tension—Epirubicin—ovarian cancer	0.000213	0.000266	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—ovarian cancer	0.000212	0.000266	CcSEcCtD
Gabapentin—Diarrhoea—Paclitaxel—ovarian cancer	0.000212	0.000265	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—ovarian cancer	0.00021	0.000263	CcSEcCtD
Gabapentin—Back pain—Epirubicin—ovarian cancer	0.00021	0.000262	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—ovarian cancer	0.000208	0.000261	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—ovarian cancer	0.000208	0.00026	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—BRIP1—ovarian cancer	0.000208	0.00396	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPP1CC—ovarian cancer	0.000208	0.00396	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000208	0.00396	CbGpPWpGaD
Gabapentin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000208	0.00026	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—ovarian cancer	0.000207	0.000259	CcSEcCtD
Gabapentin—Abdominal pain—Docetaxel—ovarian cancer	0.000207	0.000259	CcSEcCtD
Gabapentin—Chills—Doxorubicin—ovarian cancer	0.000207	0.000259	CcSEcCtD
Gabapentin—Dizziness—Paclitaxel—ovarian cancer	0.000205	0.000256	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—ovarian cancer	0.000204	0.000256	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—ovarian cancer	0.000204	0.000255	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—DLC1—ovarian cancer	0.000204	0.00388	CbGpPWpGaD
Gabapentin—Mental disorder—Doxorubicin—ovarian cancer	0.000202	0.000253	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000201	0.000252	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—ovarian cancer	0.000201	0.000251	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—ovarian cancer	0.000201	0.000251	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—ovarian cancer	0.0002	0.000251	CcSEcCtD
Gabapentin—Agitation—Epirubicin—ovarian cancer	0.000199	0.000249	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—MAPK1—ovarian cancer	0.000198	0.00378	CbGpPWpGaD
Gabapentin—Flatulence—Doxorubicin—ovarian cancer	0.000198	0.000247	CcSEcCtD
Gabapentin—Tension—Doxorubicin—ovarian cancer	0.000197	0.000246	CcSEcCtD
Gabapentin—Vomiting—Paclitaxel—ovarian cancer	0.000197	0.000246	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—ovarian cancer	0.000196	0.000246	CcSEcCtD
Gabapentin—Malaise—Epirubicin—ovarian cancer	0.000195	0.000245	CcSEcCtD
Gabapentin—Rash—Paclitaxel—ovarian cancer	0.000195	0.000244	CcSEcCtD
Gabapentin—Dermatitis—Paclitaxel—ovarian cancer	0.000195	0.000244	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—ovarian cancer	0.000195	0.000244	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—ovarian cancer	0.000195	0.000244	CcSEcCtD
Gabapentin—Syncope—Epirubicin—ovarian cancer	0.000194	0.000243	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—ovarian cancer	0.000194	0.000243	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—ovarian cancer	0.000194	0.000243	CcSEcCtD
Gabapentin—Headache—Paclitaxel—ovarian cancer	0.000194	0.000243	CcSEcCtD
Gabapentin—Hypersensitivity—Docetaxel—ovarian cancer	0.000193	0.000242	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—ovarian cancer	0.000193	0.000241	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—ovarian cancer	0.000192	0.00024	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—ovarian cancer	0.00019	0.000238	CcSEcCtD
Gabapentin—Cough—Epirubicin—ovarian cancer	0.000189	0.000237	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—ovarian cancer	0.000189	0.000236	CcSEcCtD
Gabapentin—Asthenia—Docetaxel—ovarian cancer	0.000188	0.000235	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—ovarian cancer	0.000188	0.000235	CcSEcCtD
Gabapentin—BCAT1—Metabolism—FASN—ovarian cancer	0.000188	0.00357	CbGpPWpGaD
Gabapentin—Hypertension—Epirubicin—ovarian cancer	0.000187	0.000234	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000186	0.000233	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—ovarian cancer	0.000186	0.000232	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—ovarian cancer	0.000185	0.000232	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—ovarian cancer	0.000184	0.000231	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—ovarian cancer	0.000184	0.000231	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—ovarian cancer	0.000184	0.000231	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SLC5A5—ovarian cancer	0.000184	0.00351	CbGpPWpGaD
Gabapentin—Agitation—Doxorubicin—ovarian cancer	0.000184	0.000231	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—ovarian cancer	0.000184	0.00023	CcSEcCtD
Gabapentin—Nausea—Paclitaxel—ovarian cancer	0.000184	0.00023	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000183	0.000229	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—ovarian cancer	0.000182	0.000228	CcSEcCtD
Gabapentin—Malaise—Doxorubicin—ovarian cancer	0.000181	0.000226	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—ovarian cancer	0.00018	0.000226	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—ovarian cancer	0.00018	0.000225	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—ovarian cancer	0.00018	0.000225	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—ovarian cancer	0.000179	0.000225	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—ovarian cancer	0.000179	0.000225	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—ovarian cancer	0.000178	0.000223	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SLC2A1—ovarian cancer	0.000178	0.00339	CbGpPWpGaD
Gabapentin—Palpitations—Doxorubicin—ovarian cancer	0.000177	0.000222	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000177	0.000221	CcSEcCtD
Gabapentin—Oedema—Epirubicin—ovarian cancer	0.000177	0.000221	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000176	0.000221	CcSEcCtD
Gabapentin—Infection—Epirubicin—ovarian cancer	0.000176	0.00022	CcSEcCtD
Gabapentin—Cough—Doxorubicin—ovarian cancer	0.000175	0.000219	CcSEcCtD
Gabapentin—Shock—Epirubicin—ovarian cancer	0.000174	0.000218	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—ovarian cancer	0.000174	0.000217	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—ovarian cancer	0.000173	0.000217	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—ovarian cancer	0.000173	0.000217	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000173	0.000217	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—ovarian cancer	0.000173	0.000217	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—ovarian cancer	0.000173	0.000216	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—ovarian cancer	0.000172	0.000215	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000171	0.00327	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000171	0.000214	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP1B1—ovarian cancer	0.000171	0.00325	CbGpPWpGaD
Gabapentin—Arthralgia—Doxorubicin—ovarian cancer	0.000171	0.000214	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—ovarian cancer	0.000171	0.000214	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—ovarian cancer	0.000171	0.000214	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—ovarian cancer	0.00017	0.000213	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00017	0.000212	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—ovarian cancer	0.000169	0.000211	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—ovarian cancer	0.000169	0.000211	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—ovarian cancer	0.000167	0.000209	CcSEcCtD
Gabapentin—Vomiting—Docetaxel—ovarian cancer	0.000167	0.000209	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—BCL9—ovarian cancer	0.000166	0.00316	CbGpPWpGaD
Gabapentin—Rash—Docetaxel—ovarian cancer	0.000165	0.000207	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—ovarian cancer	0.000165	0.000207	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—ovarian cancer	0.000165	0.000207	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—ovarian cancer	0.000165	0.000206	CcSEcCtD
Gabapentin—Headache—Docetaxel—ovarian cancer	0.000164	0.000206	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000164	0.000205	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—ovarian cancer	0.000164	0.000205	CcSEcCtD
Gabapentin—Infection—Doxorubicin—ovarian cancer	0.000163	0.000203	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000161	0.000202	CcSEcCtD
Gabapentin—Shock—Doxorubicin—ovarian cancer	0.000161	0.000201	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—ovarian cancer	0.00016	0.000201	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00016	0.000201	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—ovarian cancer	0.00016	0.0002	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—ovarian cancer	0.00016	0.0002	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—HRAS—ovarian cancer	0.000159	0.00303	CbGpPWpGaD
Gabapentin—Skin disorder—Doxorubicin—ovarian cancer	0.000159	0.000199	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—ovarian cancer	0.000159	0.000199	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000158	0.000198	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—ovarian cancer	0.000158	0.000197	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—ovarian cancer	0.000157	0.000197	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—ovarian cancer	0.000156	0.000195	CcSEcCtD
Gabapentin—Nausea—Docetaxel—ovarian cancer	0.000156	0.000195	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—ovarian cancer	0.000156	0.000195	CcSEcCtD
Gabapentin—Decreased appetite—Epirubicin—ovarian cancer	0.000154	0.000192	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—ovarian cancer	0.000153	0.000191	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000153	0.000191	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—ovarian cancer	0.000152	0.000191	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPP2R1A—ovarian cancer	0.000151	0.00289	CbGpPWpGaD
Gabapentin—Constipation—Epirubicin—ovarian cancer	0.000151	0.000189	CcSEcCtD
Gabapentin—Pain—Epirubicin—ovarian cancer	0.000151	0.000189	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000149	0.000187	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—ovarian cancer	0.000149	0.00284	CbGpPWpGaD
Gabapentin—Insomnia—Doxorubicin—ovarian cancer	0.000148	0.000185	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—ovarian cancer	0.000147	0.000184	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000146	0.00279	CbGpPWpGaD
Gabapentin—Dyspnoea—Doxorubicin—ovarian cancer	0.000146	0.000183	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—ovarian cancer	0.000146	0.000182	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—ovarian cancer	0.000145	0.000182	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000145	0.000181	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—ovarian cancer	0.000144	0.00018	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—ovarian cancer	0.000142	0.000178	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000141	0.000177	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—ovarian cancer	0.000141	0.000177	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ABCB1—ovarian cancer	0.000141	0.00268	CbGpPWpGaD
Gabapentin—Urticaria—Epirubicin—ovarian cancer	0.000141	0.000176	CcSEcCtD
Gabapentin—Pain—Doxorubicin—ovarian cancer	0.00014	0.000175	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—ovarian cancer	0.00014	0.000175	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—ovarian cancer	0.00014	0.000175	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—ovarian cancer	0.00014	0.000175	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—YAP1—ovarian cancer	0.000139	0.00266	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TYMS—ovarian cancer	0.000138	0.00263	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000138	0.00262	CbGpPWpGaD
Gabapentin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000135	0.000169	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000134	0.000167	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—MAPK1—ovarian cancer	0.000131	0.0025	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DOK1—ovarian cancer	0.000131	0.0025	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—ovarian cancer	0.00013	0.000163	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—ovarian cancer	0.00013	0.000163	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—ovarian cancer	0.000129	0.000162	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—ovarian cancer	0.000129	0.000162	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—ovarian cancer	0.000127	0.000159	CcSEcCtD
Gabapentin—Pruritus—Epirubicin—ovarian cancer	0.000125	0.000157	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPP1CC—ovarian cancer	0.000123	0.00235	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—ovarian cancer	0.000121	0.000151	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000121	0.000151	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—ovarian cancer	0.000117	0.000147	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—ovarian cancer	0.000117	0.000146	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000116	0.00222	CbGpPWpGaD
Gabapentin—Pruritus—Doxorubicin—ovarian cancer	0.000116	0.000145	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—FASN—ovarian cancer	0.000114	0.00216	CbGpPWpGaD
Gabapentin—Vomiting—Epirubicin—ovarian cancer	0.000112	0.000141	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—ovarian cancer	0.000112	0.00014	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—ovarian cancer	0.000112	0.00213	CbGpPWpGaD
Gabapentin—Rash—Epirubicin—ovarian cancer	0.000112	0.00014	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—ovarian cancer	0.000111	0.000139	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CAV1—ovarian cancer	0.000111	0.00212	CbGpPWpGaD
Gabapentin—Headache—Epirubicin—ovarian cancer	0.000111	0.000139	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—ovarian cancer	0.000108	0.000135	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC2A1—ovarian cancer	0.000108	0.00206	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—ovarian cancer	0.000105	0.00201	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—ovarian cancer	0.000105	0.000131	CcSEcCtD
Gabapentin—Vomiting—Doxorubicin—ovarian cancer	0.000104	0.00013	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP1B1—ovarian cancer	0.000103	0.00197	CbGpPWpGaD
Gabapentin—Rash—Doxorubicin—ovarian cancer	0.000103	0.000129	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—ovarian cancer	0.000103	0.000129	CcSEcCtD
Gabapentin—Headache—Doxorubicin—ovarian cancer	0.000103	0.000128	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—ovarian cancer	0.000102	0.00194	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—ovarian cancer	0.000101	0.00193	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—ovarian cancer	9.72e-05	0.000122	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HDAC6—ovarian cancer	9.34e-05	0.00178	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—ovarian cancer	9.31e-05	0.00177	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP2R1A—ovarian cancer	9.22e-05	0.00176	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPP2R1A—ovarian cancer	9.18e-05	0.00175	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—ovarian cancer	8.91e-05	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—ovarian cancer	8.85e-05	0.00169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCB1—ovarian cancer	8.52e-05	0.00162	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TYMS—ovarian cancer	8.37e-05	0.00159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—YAP1—ovarian cancer	8.27e-05	0.00158	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—XIAP—ovarian cancer	8.1e-05	0.00154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SMARCA4—ovarian cancer	7.9e-05	0.0015	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—ovarian cancer	7.77e-05	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EREG—ovarian cancer	7.71e-05	0.00147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PGR—ovarian cancer	7.22e-05	0.00138	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—ovarian cancer	6.79e-05	0.00129	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAV1—ovarian cancer	6.74e-05	0.00128	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PARP1—ovarian cancer	6.71e-05	0.00128	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—ovarian cancer	6.71e-05	0.00128	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6ST—ovarian cancer	6.42e-05	0.00122	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—ovarian cancer	6.17e-05	0.00118	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—ovarian cancer	6.14e-05	0.00117	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—ovarian cancer	5.97e-05	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP2R1A—ovarian cancer	5.45e-05	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—ovarian cancer	5.42e-05	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—ovarian cancer	5.4e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—ovarian cancer	5.21e-05	0.000992	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—ovarian cancer	5e-05	0.000953	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—ovarian cancer	4.78e-05	0.000911	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—ovarian cancer	4.74e-05	0.000902	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—ovarian cancer	4.73e-05	0.000901	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—ovarian cancer	4.71e-05	0.000897	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—ovarian cancer	4.54e-05	0.000866	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—ovarian cancer	4.34e-05	0.000827	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—ovarian cancer	4.33e-05	0.000824	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—ovarian cancer	4.07e-05	0.000775	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—ovarian cancer	4e-05	0.000762	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—ovarian cancer	3.87e-05	0.000737	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—ovarian cancer	3.86e-05	0.000735	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6ST—ovarian cancer	3.79e-05	0.000723	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—ovarian cancer	3.64e-05	0.000695	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—ovarian cancer	3.64e-05	0.000695	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—ovarian cancer	3.64e-05	0.000694	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—ovarian cancer	3.49e-05	0.000665	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK1—ovarian cancer	3.32e-05	0.000633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—ovarian cancer	3.32e-05	0.000633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—ovarian cancer	3.2e-05	0.000611	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—ovarian cancer	3.17e-05	0.000605	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—ovarian cancer	3.14e-05	0.000598	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—ovarian cancer	2.88e-05	0.000549	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—ovarian cancer	2.87e-05	0.000547	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—ovarian cancer	2.83e-05	0.000539	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—ovarian cancer	2.79e-05	0.000532	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—ovarian cancer	2.79e-05	0.000532	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—ovarian cancer	2.68e-05	0.000511	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—ovarian cancer	2.67e-05	0.000508	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—ovarian cancer	2.62e-05	0.000499	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—ovarian cancer	2.59e-05	0.000494	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—ovarian cancer	2.57e-05	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—ovarian cancer	2.56e-05	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—ovarian cancer	2.55e-05	0.000486	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—ovarian cancer	2.5e-05	0.000476	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—ovarian cancer	2.48e-05	0.000472	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—ovarian cancer	2.43e-05	0.000463	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—ovarian cancer	2.41e-05	0.00046	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	2.35e-05	0.000449	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—ovarian cancer	2.34e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	2.18e-05	0.000415	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—ovarian cancer	2.16e-05	0.000411	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—ovarian cancer	2.15e-05	0.00041	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	2.06e-05	0.000393	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—ovarian cancer	2.01e-05	0.000382	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	1.96e-05	0.000374	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—ovarian cancer	1.96e-05	0.000374	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—ovarian cancer	1.85e-05	0.000353	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	1.7e-05	0.000324	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—ovarian cancer	1.65e-05	0.000314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—ovarian cancer	1.58e-05	0.0003	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—ovarian cancer	1.51e-05	0.000287	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—ovarian cancer	1.39e-05	0.000265	CbGpPWpGaD
